BioRestorative Therapies, Inc.
Price Action
Technical Summary
CONSOLIDATINGBioRestorative Therapies, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 73), indicating performance broadly in line with the market. Earnings growth of 63% provides fundamental context to the price action. Investors should exercise caution due to high volatility (140% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.39 | -3.32% | BELOW |
| 50 SMA | $0.31 | +18.50% | ABOVE |
| 100 SMA | $0.29 | +29.64% | ABOVE |
| 150 SMA | $0.56 | -33.96% | BELOW |
| 200 SMA | $0.79 | -52.63% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is BRTX in an uptrend right now?
BRTX has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is BRTX overbought or oversold?
BRTX's RSI (14) is 56. The stock is in neutral territory, neither overbought nor oversold.
Is BRTX outperforming the market?
BRTX has a Relative Strength (RS) Rating of 73 out of 99. BRTX is performing about average compared to the market.
Where is BRTX in its 52-week range?
BRTX is trading at $0.37, which is 20% of its 52-week high ($1.89) and 12% above its 52-week low ($0.16).
How volatile is BRTX?
BRTX has a Beta of 2.04 and 52-week volatility of 140%. It's more volatile than the S&P 500 - expect bigger swings.